Remco Evenepoel took back-to-back stage wins in the Tour de France, and eroded some of Tadej Pogacar’s overall lead, with victory in the stage-16 time trial from Evian to Thonon-les-Bains.
- Nocturnal ITA tests visited Vingegaard and Pogacar at 2am and 5am; results unknown, leaving the Tour under a cloud of suspicion.
- ITA director Olivier Banuls said testing avoids mass testing for cost reasons and defended efforts to protect clean athletes.
- Former pro and whistleblower Christophe Bassons warned it's impossible nobody's cheating and questioned absence of positive tests.
- Red Bull-Bora-Hansgrohe rider Florian Lipowitz crashed, likely broke collarbone, and abandoned the Tour, weakening his team's prospects.
The Olympic road and time trial champion, now second overall in the Tour, won on the Belgian national day from Pogacar by 28 seconds, to reduce the Slovenian’s advantage to just over four and a half minutes. It was the third Tour time trial win of his career.
“It’s been a while since I’ve been on this level so it feels amazing to be in this good shape in the Tour,” Evenepoel said. The Belgian, who described Pogacar as a “superstar”, added: “It’s not over yet. There are still some hard stages to come.”
Pogacar’s UAE Emirates XRG teammate, Isaac del Toro, remains in third place, but Paul Seixas is now just 20sec away from a podium position after taking time on the Mexican rider in the race against the clock.
Evenepoel’s success was tempered by the loss of his Red Bull-Bora-Hansgrohe teammate, Florian Lipowitz, third in the Tour last year, who quit the race after crashing.
Lipowitz crashed on a tight right-hand bend as he exited a downhill section of the course. He was carried away from the scene on a stretcher with a suspected broken collar bone. He was the second 2025 podium finisher – after Jonas Vingegaard on Sunday – to leave the race in 72 hours.
While the race continued, the debate over the ITA drug testing agency’s nocturnal activities, which involved 2am and 5am visits to Vingegaard and Pogacar respectively last Sunday, continued.
Speaking in May this year to Reuters, Olivier Banuls, the ITA’s director of testing, said: “We do a lot of testing but we don’t do mass testing. To do mass testing is to throw money out the window.”
The outcome of the tests on both riders, however, remains unknown, leaving the Tour in a state of limbo, carrying on regardless, despite the cloud of suspicion that hangs over Pogacar who is closing in on what would be a record-equalling fifth Tour win.
The former professional rider Christophe Bassons, who was a whistleblower during the Lance Armstrong era and who now works to combat the trafficking of doping products for the French ministry of sports, said that it was “impossible that nobody’s cheating”.
Bassons told RMC sport: “I think the absence of positive tests [in cycling] is not a good sign. If the testing methods have improved, then so have the methods of avoiding detection.”
Banuls rejected the notion that a lack of positive tests in recent Tours de France implied that the sport was clean. “We are not blind,” he told Reuters. “We are not naive. We are doing the best possible job to protect the sport and the clean athletes, and to try to find those who cheat.”
